Home › Smoldering Multiple Myeloma › Ohio
Smoldering Multiple Myeloma clinical trials in Ohio
3 studies for Smoldering Multiple Myeloma are looking for participants at sites in Ohio.
Cities in Ohio
A Study to Compare Linvoseltamab and Daratumumab Treatment in High-Risk Smoldering Multiple Myeloma (HR-SMM)
- Ohio State University, Columbus
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT07393282Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
- Indu and Raj Soin Medical Center, Beavercreek
- Saint Elizabeth Boardman Hospital, Boardman
- Aultman Health Foundation, Canton
- and 52 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Aug 19, 2026 · NCT03937635Screening for AL Amyloidosis in Smoldering Multiple Myeloma
- The Ohio State University Comprehensive Cancer Center, Columbus
RecruitingObservational study
Ages 40 and older · All sexes · Updated Aug 6, 2025 · NCT06365060From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.